Kevin Hakimi, Ava Saidian, Justine Panian, Pedro Barata, Stephanie Berg, Steven L Chang, Renee M Saliby, Hannah Dzimitrowicz, Hamid Emamekhoo, Evan Gross, Deepak Kilari, Elaine Lam, Mimi Nguyen, Margaret Meagher, Luke Wang, Grant P Rauterkus, Vincent D'Andrea, Kendrick Yim, Sarah Psutka, Bicky Thapa, Nicole Weise, Tian Zhang, Rana R McKay, Ithaar H Derweesh
BACKGROUND: To evaluate effect and outcomes of combination primary immunotherapy (IO) and nephrectomy for advanced renal cell carcinoma (RCC). METHODS: We conducted a multicenter, retrospective analysis of patients with advanced/metastatic RCC who received IO followed by nephrectomy. Primary outcome was Bifecta (negative surgical margins and no 30-day surgical complications). Secondary outcomes included progression-free survival (PFS) following surgery, reduction in tumor/thrombus size, RENAL score, and clinical/pathologic downstaging...
July 19, 2023: Clinical Genitourinary Cancer